YERVOY

Medicinal product

(Invented) name

YERVOY

Active substance (s)

Ipilimumabas

Strength

5 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX04, Ipilimumab

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2011-07-13

Date of renewal

Documents

YERVOY paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Ipilimumabas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47828	61650	1061650	flakonas	10 ml N1		Receptinis	EU/1/11/698/001	Netiekiama	2024-12-20	2025-12-31	Yes	2025-01-01	2025-12-31
47829	61651	1061651	flakonas	40 ml N1		Receptinis	EU/1/11/698/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2011-07-13	Registruotas